Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Crestwood Midstream Partners Q4 Profit Plunges - Quick Facts

Crestwood Midstream Partners LP (CMLP: Quote) Tuesday reoported fourth-quarter profit of $4.86 million, down from $12.34 million in the comparable quarter last year.

General partner's interest in earnings was $4.13 million, compared to $2.79 million last year.

Limited partners' interest plunged to $0.73 million or $0.01 per share from $9.55 million or $0.24 per share last year.

Adjusted earnings for the period was $119.3 million or $0.03 per share. On average, seven analysts polled by Thomson Reuters expecetd the company to earn $0.25 per share for the quarter. Analysts' estimates typically exclude special items.

Operating revenues totaled $56.99 million, down from $59.29 million last year. Analysts expected revenues of $61.76 million.

Looking ahead to the fiscal year 2013, the company expects adjusted EBITDA in a range of $170 million to $185 million.

Click here to receive FREE breaking news email alerts for Crestwood Midstream Partners LP and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Colorado based doctor Dilip Joseph, who was kidnapped by the Taliban discusses his ordeal in detail in a book published by Amazon on Tuesday. Extending the rebound seen over the course of the previous session, stocks moved sharply higher during trading on Friday. The gains on the day partly offset the recent sell-off on Wall Street, although the major averages remain well off their mid-September highs. While the Ebola outbreak in the U.S. has thus far been limited to just three people, the results of a new CBS News poll suggest that news of the disease has contributed to a sharp drop in public confidence in the Centers for Disease Control and Prevention.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.